RayGel-An Alternative for Skin Care During External Beam Radiation

Completed · Phase 2

Conditions studied: Breast Cancer

In brief

This study is for the patient with breast cancer. To take part in this study, external beam radiation therapy needs to be part of the treatment plan. Reduced glutathione, an ingredient of RayGel™, has been helpful in decreasing some radiation therapy side effects to the skin. Reduced glutathione plays a vital role in both making DNA and cell repair. This study will measure if RayGel decreases skin reaction in breast cancer patients treated with external beam radiation therapy.

Key facts

Study ID

NCT00266331

Run by

Nathalie Johnson

People needed

150

Starts

2004-10-01

Expected to finish

2011-05-01

Last updated by the study team

2013-08-28

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Breast Cancer
• Radiation

You may not qualify if…

• Post Mastectomy
• Previous irradiation of the same breast
• Pregnacy
• Younger than 18 years of age

Where it is running

• Legacy Health System — Portland, Oregon, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.